Wilson's disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age and gender are unrestricted; participants must meet the disease diagnostic criteria; no prior treatment before admission; complete clinical records required for this study.
Exclusion criteria
Exclusion criteria: Subjects with a clear diagnosis of hepatic fibrosis or cirrhosis and inability to obtain clinical data; patients with fulminant hepatic failure (with or without hemolytic anemia) and decompensated cirrhosis; pregnant or breastfeeding women, or women intending to become pregnant; patients with other severe diseases (e.g., malignant tumors, hematopoietic system disorders).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum ceruloplasmin;Serum copper oxidase activity;Serum copper;24-hour urinary copper;Sheth Index;APRI Index;FIB-4 index;GPR model;Hyaluronic acid;Type IV collagen;Laminin;Type III procollagen N-terminal peptide;Digestive System Ultrasound Examination;Cranial imaging examination;Clinical Investigation of Traditional Chinese Medicine; | — |
Secondary
| Measure | Time frame |
|---|---|
| Age;Gender;Ethnic group;Allergy History;Marital Status;Body Mass Index;Confirmation Date;Presenting symptom;Disease classification;Corneal K-F ring;ATP7B Genetic Testing;disease course;Treatment Plan;HBV Infection Status;HCV Infection Status;Do you smoke?;Do you drink alcohol?; | — |
Countries
China
Contacts
The First Affiliated Hospital of Anhui University of Chinese Medicine